Islay Capital Management’s Medtronic MDT Stock Holding History

Islay Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-65	Closed	-$5.05K	–	251
2022 Q4	$5.05K	Hold	65	–	–	0.01%	211
2022 Q3	$5K	Hold	65	–	–	0.01%	222
2022 Q2	$6K	Hold	65	–	–	0.01%	249
2022 Q1	$7K	Hold	65	–	–	0.01%	256
2021 Q4	$7K	Buy	+65	New	+$7.53K	0.01%	255
2021 Q3	–	Sell	-200	Closed	-$25K	–	297
2021 Q2	$25K	Hold	200	–	–	0.02%	222
2021 Q1	$24K	Sell	200 -400	-67%	-$46.9K	0.02%	207
2020 Q4	$70K	Hold	600	–	–	0.06%	158
2020 Q3	$62K	Hold	600	–	–	0.06%	166
2020 Q2	$55K	Buy	600 +200	+50%	+$19.2K	0.06%	161
2020 Q1	$36K	Hold	400	–	–	0.05%	163
2019 Q4	$45K	Buy	+400	New	+$43.9K	0.04%	172

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Islay Capital Management's MDT Position: Q1 2023 in Review

Islay Capital Management sold out of Medtronic (MDT) in Q1 2023, closing a stake of 65 shares — an estimated $5.05K sold.

Islay Capital Management first reported a position in MDT in Q4 2019 and held it in 12 quarters. The position peaked at $70K in Q4 2020. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

Islay Capital Management reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
Islay Capital Management sold 65 Medtronic shares in Q1 2023, an estimated $5.05K.
Islay Capital Management first reported a position in Medtronic in Q4 2019 and held it in 12 quarters.
Islay Capital Management's Medtronic position peaked at $70K in Q4 2020.
1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Islay Capital Management's 13F filing for Q1 2023, filed 10 May 2023.